15 news items
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results
ABBV
JNJ
LLY
29 May 24
, tax, investment, financial, or other advice. No content in this article constitutes an offer or solicitation by InvestorBrandMedia.com or any third
Performance Comparison: Merck & Co And Competitors In Pharmaceuticals Industry
MRK
21 May 24
.
Compared to its industry, the company has lower Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $6.96
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
ABBV
JNJ
LLY
21 May 24
or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content
Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions
ABBV
ATNM
AZN
8 May 24
or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content
Ligand Reports First Quarter 2024 Financial Results
AMGN
CASI
JAZZ
7 May 24
equity investments in public companies, excess tax benefit from share-based compensation, income tax effect of adjusted reconciling items and others
5b23swo uh2j2avavnbqja2pw3bunnp
MRK
7 May 24
.
The company has lower Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $6.96 Billion, which
6n75g
MRK
25 Apr 24
expense in 2024.
The effective tax rate was 15.9% for the first quarter of 2024 (which includes a 1.6
htuu5aaq02iwemsdywyouf5lq2pp9
MRK
23 Apr 24
to various factors.
Compared to its industry, the company has lower Earnings Before Interest, Taxes, Depreciation, and Amortization
vnqjy6zyguk3 09ntr
ABBV
ATNM
AZN
22 Apr 24
informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content in this article constitutes an offer
3g0x6cb5upob4frnvoer2krh3y5f1ihpdum8igai5jmkoy1x9 e4ol
ABBV
ATNM
AZN
19 Apr 24
a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content in this article
kzvrh8i9ziafsmlyrbd5hsnp6r8n24iiabw83m57s7ndteosd85
MRK
MRNA
11 Apr 24
, aimed at finalizing the deal were in vain. Despite tax breaks and reduced investment requirements from the Kenyan government, Moderna has stalled
szetbaibfxav414j71zzhm9k 1rzebmuzy
MRK
8 Apr 24
potential inefficiency in utilizing equity to generate profits.
With lower Earnings Before Interest, Taxes, Depreciation, and Amortization
03mpcwqdjv 30ep7ed1d27aa46s4y65o991s1
ABBV
ANIX
BIIB
20 Mar 24
a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice
9f4xf5m6gds4w1bw1pnlc7tmal3jlvp 4epehwdyka5hz
MRK
13 Mar 24
.
The company has lower Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $-770 Million, which is -0.03x
xhmsmtyqt5f3iezpgxzjoqx0 f957ft8wloaxf
HARP
MRK
11 Mar 24
outstanding shares of Harpoon. As previously disclosed, this transaction is being accounted for as an asset acquisition. Merck is recording a non-tax
- Prev
- 1
- Next